Ownership history in UBS Group AG · 3 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in GRI BIO INC (GRI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 27 | -15,428 | -99.8% | 0.00% | $56 | $57.68 |
| 2025 Q2 | ADDED | 15,455 | +12,210 | +376.3% | 0.00% | $20K | $36.12 |
| 2025 Q1 | INITIATED | 3,245 | — | — | 0.00% | $10K | $89.60 |
As of 2025 Q4 — sorted by position size